Search

everythinglearnresearchcommunity

for

Search:↓

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

Upadacitinib and oral minoxidil improved Crohn's disease and hair regrowth in a patient.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

Avacopan may cause unexpected side effects, so early monitoring is important.

Tildrakizumab significantly improved psoriasis symptoms and well-being over 52 weeks.

Low and ultralow doses of flutamide can cause liver damage in young women with high androgen levels, regardless of dose or birth control use, with higher risk for those with higher BMI and liver enzyme levels before treatment.

Ruxolitinib can cause a delayed skin reaction on the nose.

The compound zishenqing formula is effective and safe for treating mild to moderate systemic lupus erythematosus.

Botulinum Toxin Type A delivered through the skin may be a promising treatment for Frontal Fibrosing Alopecia.

Patients with systemic lupus erythematosus and hair loss had fewer hair follicles and non-scarring alopecia; direct immunofluorescence was not helpful in diagnosing lupus in these cases.

Deuruxolitinib significantly helps regrow scalp hair in adults with moderate to severe alopecia areata.

The treatment helped reduce symptoms and stabilize the hairline in most patients with Frontal Fibrosing Alopecia, but hair regrowth was limited.

Acitretin effectively improved the woman's skin condition.

BIVV009 is a safe treatment for bullous pemphigoid that reduces C3 deposition without harmful side effects.

Cutaneous lupus patients have higher levels of certain immune cells in their blood and skin.

Upadacitinib improved hair regrowth and quality of life in alopecia areata patients with minimal side effects.

Lymecycline may help with Frontal Fibrosing Alopecia but needs more research.

The method could improve vitiligo treatment by effectively delivering therapy to hair follicles.

Fat tissue transplant may be an effective new treatment for severe, treatment-resistant hair loss from folliculitis decalvans.

Topical Ruxolitinib may safely treat severe hair loss.

Bicalutamide, a drug with a good safety profile, is a promising new treatment for female pattern hair loss.

TNF-α blockers and IL inhibitors improve symptoms in most patients with severe scalp condition, but more research is needed.

IFAP syndrome is a rare genetic disorder causing skin, hair, and eye issues, with limited treatment options.

hUC-MSC secretome can help regrow hair in cases of hair loss.

Infliximab improved skin and bowel symptoms in Crohn's disease but caused side effects and the disease returned after stopping treatment.

Effective immunomodulatory treatments and a personalized approach are crucial for managing severe folliculitis decalvans.

Baricitinib effectively treats alopecia areata, with over half of patients improving after 52 weeks.

A lotion with minoxidil, hydrocortisone butyrate, and 17a-estradiol can improve or stabilize Frontal Fibrosing Alopecia in some cases, but there's no universally-accepted treatment yet.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.